Topics

Forbion Capital Partners Company Profile

09:42 EDT 17th October 2019 | BioPortfolio

Forbion Capital Partners is a Netherlands-based venture capital firm focused on investing in life sciences companies in drug development as well as MedTech companies addressing high medical needs. Forbion’s investment team of nine investment professionals has built an impressive performance track record since the late nineties with successful investments in Rhein Biotech, Crucell, Neutec, Glycart, Borean, Impella, Alantos, Acorda, Fovea and PanGenetics. Current assets under management exceed €400m ($500m), split between three active funds. Finally, Forbion co-manages BioGeneration Ventures, an early stage fund focused on academic spin-outs and seed investments in the Netherlands.


News Articles [1015 Associated News Articles listed on BioPortfolio]

Forbion Capital Partners: Geert-Jan Mulder. Optimising commercial potential of portfolio company's products and technologies

In this episode of PharmaTelevision News Review, filmed at BioEurope 2012 in Hamburg, Germany, Fintan Walton talks to Geert-Jan Mulder, General Partner at Forbion Capital Partners

Forbion Capital Partners : Philip Astley-Sparke, Enabling the development of truly innovative medicines and devices

In this episode of PharmaTelevision News Review, filmed at BioPharm America in Boston, Fintan Walton talks to Philip Astley-Sparke, Venture Partner at Forbion Capital Partners

Marco Boorsma describes Forbion Capital Partners’ investment strategy and gives his personal perspective on the future of the Biotech sector

In this episode of PharmaTelevision News Review, Fintan Walton talks to Marco Boorsma, Senior Analyst at Forbion

Series D round brings €55.2mm to Sanifit

Laboratoris Sanifit SL (treatments for vascular calcification disorders) raised €55.2mm ($62.8mm) in its Series D round led by Caixa Capital Risc. New investors Columbus Venture Partners and Alta Li...

Forbion’s General Partner Sander van Deventer discusses game changing investments.

Sander van Deventer, General Partner at Forbion Capital former & interim CEO of Dezima PharmaPartners talks to Fintan Walton about the game changing Pharma and Biotech companies Forbion is investing i...

AM-Pharma closes €116mm Series F round

AM-Pharma BV raised €116mm ($133mm) through its Series F round co-led by new investors LSP (Life Sciences Partners) and Andera Partners. Returning backers Forbion, Ysios Capital, Kurma Partners, IDI...

Health Tech VC Firm Flare Capital Partners Closes $255M Fund

Healthcare technology venture capital firm, Flare Capital Partners, today announced the closing of its second fund, Flare Capital Partners II, L.P., with a total of $255 million in committed capital. ...

Pharvaris gets $66mm via Series B

Cardiovascular-focused start-up Pharvaris BV raised $66mm in its Series B financing round led by led by Foresite Capital, which was joined by Bain Capital Life Sciences, venBio Partners, and Venrock P...

Drugs and Medications [67 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [respiratory care partners, inc]

Oxygen

Moderiba [abbvie inc.]

These highlights do not include all the information needed to use Moderiba (ribavirin, USP) safely and effectively. See full prescribing information for Moderiba (ribavirin, USP). Moderiba (ribavirin,...

Ribavirin [sandoz inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. RIBAVIRIN tablets, for oral useIniti...

Ribavirin [richmond pharmaceuticals, inc.]

These highlights do not include all the information needed to use ribavirin tablets safely and effectively. See full prescribing information for ribavirin tablets. Ribavirin Tablets for oral useInitia...

Ribavirin [aurobindo pharma limited]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. RIBAVIRIN tablets, for oral use Init...

PubMed Articles [359 Associated PubMed Articles listed on BioPortfolio]

Social capital and physical health: An updated review of the literature for 2007-2018.

Social capital is frequently indicated as a determinant of population health. Despite an increase in the frequency of public health studies including such measures, our understanding of social capital...

Community-Based Cognitive Social Capital and Depressive Symptoms Among Older Adults in Urban China: The Moderating Role of Family Social Capital.

The present study examined the moderating role of family social capital in the relationship between community-based cognitive social capital and depressive symptoms among community-dwelling older adul...

The opioid crisis and the infrastructure of social capital.

This paper reflects upon ethnographic work carried out in a suburban Massachusetts town that has experienced particularly high rates of opioid mis/use. In open-ended conversations, residents attribute...

Return on capital? Determinants of counter-migration among early career Israeli STEM researchers.

Migration studies emphasize the role of economic, social and cultural capital in shaping out-migration decisions. Yet, little attention is paid to the effect of capital endowment on return migration, ...

Investigating the impact of human capital on the ecological footprint in India: An empirical analysis.

Many recent studies have focused on the influencing factors of the ecological footprint, but less attention has been given to human capital. Human capital, which is based on education and rate of retu...

Clinical Trials [478 Associated Clinical Trials listed on BioPortfolio]

Social Capital and Engagement in Care Among Young Black Men Who Have Sex With Men Living With HIV

The study is a randomized controlled trial to evaluate the social capital intervention versus a general health promotion intervention (Health for Life; H4L) among groups of Young black men...

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Teachers and Parents as Partners During Middle School RCT

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Companies [1996 Associated Companies listed on BioPortfolio]

Forbion Capital Partners

Forbion Capital Partners is a Netherlands-based venture capital firm focused on investing in life sciences companies in drug development as well as MedTech companies addressing hi...

Oak Hill Capital Partners

Oak Hill Capital Partners is a private equity firm with more than $8.2 billion of committed capital from leading entrepreneurs, endowments, foundations, corporations, pension fund...

Dezima Pharma

Dezima Pharma was founded in 2012 by Prof. John Kastelein, Professor of Medicine at the Department of Vascular Medicine at the Academic Medical Center of the University of Amsterd...

Morgan Stanley Capital Partners

Morgan Stanley Capital Partners, part of Morgan Stanley Investment Management, is a leading middle-market private equity platform that has invested capital in a broad spectrum of ...

Thompson Street Capital Partners

Thompson Street Capital Partners has $450 million in capital under management. The private equity firm makes investments in manufacturing, service and distribution businesses. The fund's philosophy is...

More Information about "Forbion Capital Partners" on BioPortfolio

We have published hundreds of Forbion Capital Partners news stories on BioPortfolio along with dozens of Forbion Capital Partners Clinical Trials and PubMed Articles about Forbion Capital Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Forbion Capital Partners Companies in our database. You can also find out about relevant Forbion Capital Partners Drugs and Medications on this site too.

Quick Search

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record